NRC Health (NRC) Q4 2023 Earnings Call

Investor webinar replay

Replay transcript excerpt

will be in a listen-only mode. There will be a Q&A. To register a question, please press Start, followed by 1 on your telephone keypad. If you change your mind, please press Start, followed by 2. At this time, I would like to turn the conference over to Kevin Karras, Chief Financial Officer. Please go ahead when you are ready. Thank you, Drew. And welcome, everyone, to today's National Research Corporation earnings call. Joining me on the call today is Linda Stacey, our Vice President of Finance. Before we continue, I would like to ask Linda to review conditions related to any forward-looking statements that may be made as part of today's call. Linda? Thank you, Kevin. This conference call includes forward-looking statements related to the company that involve risks and uncertainties that could cause actual results or outcomes to differ materially from those currently anticipated. These forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. For further information about the facts that could affect the company's future results, please see the company's filings with the Security and Exchange Commission. With that, I'll turn it back to you, Kevin. Thanks, Linda. And again, welcome, everyone. Today, first we'll talk about our strategy and addressable market, then we'll cover financial details regarding the fourth quarter and provide a few thoughts about our outlook for 2024 before opening for Q&A. As an opening matter, I'd say the past few quarters have been relatively flat from a top and bottom line perspective, but a lot has been going on behind the scenes, and we're very excited about the base we're building and the direction of our strategic plan. Several quarters ago, we reset our strategy ...